Global Dextrose Injection Market Growth (Status and Outlook) 2023-2029

Global Dextrose Injection Market Growth (Status and Outlook) 2023-2029

Dextrose is also called as glucose as they are chemically identical. It plays a vital role in providing energy to body cells. Dextrose Injection is a non-pyrogenic and sterile solution for caloric supply and fluid replenishment by a single dose. Route of administration of dextrose injection is intravenous i.e. into the vein. Dosage of dextrose injection depends upon weight, age, and clinical condition of the patient. Dextrose 5% in water is injected into the vein to replace lost fluids and also provide carbohydrates to the body. Dextrose 5% in water is also used to treat hypoglycemia (low blood sugar), insulin shock and dehydration (fluid loss). Dextrose is a carbohydrate which is a part of nutrition. Dextrose solution along with amino acids and fats provide nutrition the body. This is called as total parental nutrition. Hyperkalemia is a condition in which potassium levels are high. Dextrose solution (50%) is administered to person suffering from hyperkalemia.

LPI (LP Information)' newest research report, the “Dextrose Injection Industry Forecast” looks at past sales and reviews total world Dextrose Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Dextrose Injection sales for 2023 through 2029. With Dextrose Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dextrose Injection industry.

This Insight Report provides a comprehensive analysis of the global Dextrose Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dextrose Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dextrose Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dextrose Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dextrose Injection.

The global Dextrose Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Increasing number of launches pertaining to novel dextrose injection products by key players in the market is expected to drive market growth. For instance in 2018, SteriMAx Inc., engaged in production, development, marketing and distribution of essential hospital and retail pharmacy products, launched new drug Bupivacaine Hydrochloride in 8.25% dextrose injection indicated for spinal anesthesia. It is a subarachnoid injection (spinal block).

This report presents a comprehensive overview, market shares, and growth opportunities of Dextrose Injection market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection

Segmentation by application
First-Aid Treatment
Sports
Trophotherapy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Amphastar
ChanGee
Seqirus
Baxter
Shandong Qidu Pharmaceutical
Sanctus Drugs & Pharmaceuticals
Mountainside Medical
Hospira
B Braun

Please note: The report will take approximately 2 business days to prepare and deliver.